Australia markets open in 16 minutes

IMUX Jan 2025 2.500 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.10000.0000 (0.00%)
At close: 03:42PM EDT
Full screen
Previous close0.1000
Open0.1000
Bid0.0500
Ask0.2000
Strike2.50
Expiry date2025-01-17
Day's range0.1000 - 0.1000
Contract rangeN/A
Volume10
Open interestN/A
  • Simply Wall St.

    When Will Immunic, Inc. (NASDAQ:IMUX) Breakeven?

    With the business potentially at an important milestone, we thought we'd take a closer look at Immunic, Inc.'s...

  • PR Newswire

    Immunic to Participate in Industry and Scientific Conferences in June

    Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following industry and scientific conferences in June:

  • Insider Monkey

    Immunic, Inc. (NASDAQ:IMUX) Q1 2024 Earnings Call Transcript

    Immunic, Inc. (NASDAQ:IMUX) Q1 2024 Earnings Call Transcript May 8, 2024 Immunic, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Jessica Breu: Good morning, and welcome to Immunic First Quarter 2024 Earnings Call. My name is Jessica Breu, Vice President, […]